These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 32903118)
1. Effects of progestin-only contraceptives on the endometrium. Bastianelli C; Farris M; Bruni V; Rosato E; Brosens I; Benagiano G Expert Rev Clin Pharmacol; 2020 Oct; 13(10):1103-1123. PubMed ID: 32903118 [TBL] [Abstract][Full Text] [Related]
2. Control of fertility with oral medication. Diddle AW; Watts GF; Gardner WH; Williamson PJ West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556 [TBL] [Abstract][Full Text] [Related]
3. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Rivera R; Yacobson I; Grimes D Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1263-9. PubMed ID: 10561657 [TBL] [Abstract][Full Text] [Related]
4. New knowledge in the physiology of hormonal contraceptives. Lobo RA; Stanczyk FZ Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1499-507. PubMed ID: 8178898 [TBL] [Abstract][Full Text] [Related]
5. Progestin-only oral contraception: a comprehensive review. McCann MF; Potter LS Contraception; 1994 Dec; 50(6 Suppl 1):S1-195. PubMed ID: 10226677 [TBL] [Abstract][Full Text] [Related]
6. Review of newer contraceptive agents. Qureshi M; Attaran M Cleve Clin J Med; 1999 Jun; 66(6):358-66. PubMed ID: 10375845 [TBL] [Abstract][Full Text] [Related]
7. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response. Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746 [TBL] [Abstract][Full Text] [Related]
8. Clinical profile of contraceptive progestins. Benagiano G; Primiero FM; Farris M Eur J Contracept Reprod Health Care; 2004 Sep; 9(3):182-93. PubMed ID: 15697108 [TBL] [Abstract][Full Text] [Related]
9. [Hormonal contraception]. Van Cauwenberge JR Rev Med Liege; 1992 May; 47(5):221-36. PubMed ID: 1604074 [TBL] [Abstract][Full Text] [Related]
10. [Customization of hormonal contraception]. DE Leo V; Cianci A; DI Carlo C; Cappelli V; Fruzzetti F Minerva Ginecol; 2018 Feb; 70(1):1-26. PubMed ID: 29347814 [TBL] [Abstract][Full Text] [Related]
11. Hormonal implants: contraception for a new century. Darney PD Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903 [TBL] [Abstract][Full Text] [Related]
12. Exogenous progestins and breast cancer. Stanford JL; Thomas DB Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216 [TBL] [Abstract][Full Text] [Related]
13. The endometrium and hormonal contraceptives. Benagiano G; Pera A; Primiero FM Hum Reprod; 2000 Jun; 15 Suppl 1():101-18. PubMed ID: 10928423 [TBL] [Abstract][Full Text] [Related]
14. Ovarian and endometrial function during hormonal contraception. ESHRE Capri Workshop Group Hum Reprod; 2001 Jul; 16(7):1527-35. PubMed ID: 11425842 [TBL] [Abstract][Full Text] [Related]
15. Coexpression of fractalkine and its receptor in normal human endometrium and in endometrium from users of progestin-only contraception supports a role for fractalkine in leukocyte recruitment and endometrial remodeling. Hannan NJ; Jones RL; Critchley HO; Kovacs GJ; Rogers PA; Affandi B; Salamonsen LA J Clin Endocrinol Metab; 2004 Dec; 89(12):6119-29. PubMed ID: 15579768 [TBL] [Abstract][Full Text] [Related]
16. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins. Crook D; Godsland IF; Wynn V Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933 [TBL] [Abstract][Full Text] [Related]
18. The sexuological impact of hormonal contraceptives based on their route of administration. Guida M; Di Carlo C; Troisi J; Gallo A; Cibarelli F; Martini E; Tiranini L; Nappi RE Gynecol Endocrinol; 2017 Mar; 33(3):218-222. PubMed ID: 27908210 [TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 4. Effects on uterine and cervical epithelia. Bastianelli C; Farris M; Bruni V; Brosens I; Benagiano G Expert Rev Clin Pharmacol; 2020 Feb; 13(2):163-182. PubMed ID: 31975619 [No Abstract] [Full Text] [Related]
20. Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study. Byrne EH; Anahtar MN; Cohen KE; Moodley A; Padavattan N; Ismail N; Bowman BA; Olson GS; Mabhula A; Leslie A; Ndung'u T; Walker BD; Ghebremichael MS; Dong KL; Kwon DS Lancet Infect Dis; 2016 Apr; 16(4):441-8. PubMed ID: 26723758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]